Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - Anixa Biosciences Inc | exhibit21.htm |
| EX-3.8 - EXHIBIT 3.8 - Anixa Biosciences Inc | exhibit3_8.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | exhibit31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | exhibit31_2.htm |
| EX-23.1 - EXHIBIT 23.1 - Anixa Biosciences Inc | exhibit23_1.htm |
| EX-32.2 - EXHIBIT 32.2 - Anixa Biosciences Inc | exhibit32_2.htm |
| 10-K - FORM 10-K - Anixa Biosciences Inc | form10k.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
|
| 1. | The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: January 9, 2020 |
| /s/ Amit Kumar |
|
|
|
| Dr. Amit Kumar |
|
|
|
| Chairman of the Board, President |
|